These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 31913510)
1. Screening young adult cancer survivors with the PROMIS Depression Short Form (PROMIS-D-SF): Comparison with a structured clinical diagnostic interview. Recklitis CJ; Blackmon JE; Chang G Cancer; 2020 Apr; 126(7):1568-1575. PubMed ID: 31913510 [TBL] [Abstract][Full Text] [Related]
2. Validating the Patient-Reported Outcomes Measurement Information System Short Form v1.0-Anxiety 8a in a sample of young adult cancer survivors: Comparison with a structured clinical diagnostic interview. Recklitis CJ; Blackmon JE; Chevalier LL; Chang G Cancer; 2021 Oct; 127(19):3691-3697. PubMed ID: 34196978 [TBL] [Abstract][Full Text] [Related]
3. Screening young adult cancer survivors for distress with the Distress Thermometer: Comparisons with a structured clinical diagnostic interview. Recklitis CJ; Blackmon JE; Chang G Cancer; 2016 Jan; 122(2):296-303. PubMed ID: 26457669 [TBL] [Abstract][Full Text] [Related]
4. Validity of the Brief Symptom Inventory-18 (BSI-18) for identifying depression and anxiety in young adult cancer survivors: Comparison with a Structured Clinical Diagnostic Interview. Recklitis CJ; Blackmon JE; Chang G Psychol Assess; 2017 Oct; 29(10):1189-1200. PubMed ID: 28080106 [TBL] [Abstract][Full Text] [Related]
5. Screening young adult cancer survivors for depression and anxiety with the Primary Care Evaluation of Mental Disorders (PRIME-MD): Comparisons with a structured clinical diagnostic interview. Chevalier LL; Blackmon JE; Roman A; Chang G; Recklitis CJ Psychooncology; 2023 Jul; 32(7):1122-1129. PubMed ID: 37221443 [TBL] [Abstract][Full Text] [Related]
6. Validation of the Insomnia Severity Index (ISI) for identifying insomnia in young adult cancer survivors: comparison with a structured clinical diagnostic interview of the DSM-5 (SCID-5). Michaud AL; Zhou ES; Chang G; Recklitis CJ Sleep Med; 2021 May; 81():80-85. PubMed ID: 33640841 [TBL] [Abstract][Full Text] [Related]
7. What is the best screening test for depression in chronic spinal pain patients? Choi Y; Mayer TG; Williams MJ; Gatchel RJ Spine J; 2014 Jul; 14(7):1175-82. PubMed ID: 24225008 [TBL] [Abstract][Full Text] [Related]
8. Screening for depressive symptoms in patients with chronic spinal pain using the SF-36 Health Survey. Walsh TL; Homa K; Hanscom B; Lurie J; Sepulveda MG; Abdu W Spine J; 2006; 6(3):316-20. PubMed ID: 16651227 [TBL] [Abstract][Full Text] [Related]
9. Validation of the Three-Item Insomnia Severity Index Short Form in Young Adult Cancer Survivors: Comparison with a Structured Diagnostic Interview. Chevalier LL; Michaud AL; Zhou ES; Chang G; Recklitis CJ J Adolesc Young Adult Oncol; 2022 Dec; 11(6):596-599. PubMed ID: 35085459 [TBL] [Abstract][Full Text] [Related]
10. A three-tier process for screening depression and anxiety among children and adolescents with cancer. Yardeni M; Abebe Campino G; Bursztyn S; Shamir A; Mekori-Domachevsky E; Toren A; Gothelf D Psychooncology; 2020 Dec; 29(12):2019-2027. PubMed ID: 32691478 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic operating characteristics of PROMIS scales in screening for depression. Kroenke K; Stump TE; Kean J; Krebs EE; Damush TM; Bair MJ; Monahan PO J Psychosom Res; 2021 Aug; 147():110532. PubMed ID: 34052655 [TBL] [Abstract][Full Text] [Related]
12. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors. Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787 [TBL] [Abstract][Full Text] [Related]
13. The sensitivity of the MOS SF-12 and PROMIS® global summary scores to adverse health events in an older cohort. Allen J; Alpass FM; Stephens CV Qual Life Res; 2018 Aug; 27(8):2207-2215. PubMed ID: 29725968 [TBL] [Abstract][Full Text] [Related]
14. PROMIS depression measures perform similarly to legacy measures relative to a structured diagnostic interview for depression in cancer patients. Clover K; Lambert SD; Oldmeadow C; Britton B; King MT; Mitchell AJ; Carter G Qual Life Res; 2018 May; 27(5):1357-1367. PubMed ID: 29423755 [TBL] [Abstract][Full Text] [Related]
15. Interpretation of PROMIS Depression and Anxiety Measures Compared with DSM-5 Diagnostic Criteria in Musculoskeletal Patients. Cheng AL; Downs DL; Brady BK; Hong BA; Park P; Prather H; Hunt DM JB JS Open Access; 2023; 8(1):. PubMed ID: 36698984 [TBL] [Abstract][Full Text] [Related]
16. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. Levis B; Sun Y; He C; Wu Y; Krishnan A; Bhandari PM; Neupane D; Imran M; Brehaut E; Negeri Z; Fischer FH; Benedetti A; Thombs BD; ; Che L; Levis A; Riehm K; Saadat N; Azar M; Rice D; Boruff J; Kloda L; Cuijpers P; Gilbody S; Ioannidis J; McMillan D; Patten S; Shrier I; Ziegelstein R; Moore A; Akena D; Amtmann D; Arroll B; Ayalon L; Baradaran H; Beraldi A; Bernstein C; Bhana A; Bombardier C; Buji RI; Butterworth P; Carter G; Chagas M; Chan J; Chan LF; Chibanda D; Cholera R; Clover K; Conway A; Conwell Y; Daray F; de Man-van Ginkel J; Delgadillo J; Diez-Quevedo C; Fann J; Field S; Fisher J; Fung D; Garman E; Gelaye B; Gholizadeh L; Gibson L; Goodyear-Smith F; Green E; Greeno C; Hall B; Hampel P; Hantsoo L; Haroz E; Harter M; Hegerl U; Hides L; Hobfoll S; Honikman S; Hudson M; Hyphantis T; Inagaki M; Ismail K; Jeon HJ; Jetté N; Khamseh M; Kiely K; Kohler S; Kohrt B; Kwan Y; Lamers F; Asunción Lara M; Levin-Aspenson H; Lino V; Liu SI; Lotrakul M; Loureiro S; Löwe B; Luitel N; Lund C; Marrie RA; Marsh L; Marx B; McGuire A; Mohd Sidik S; Munhoz T; Muramatsu K; Nakku J; Navarrete L; Osório F; Patel V; Pence B; Persoons P; Petersen I; Picardi A; Pugh S; Quinn T; Rancans E; Rathod S; Reuter K; Roch S; Rooney A; Rowe H; Santos I; Schram M; Shaaban J; Shinn E; Sidebottom A; Simning A; Spangenberg L; Stafford L; Sung S; Suzuki K; Swartz R; Tan PLL; Taylor-Rowan M; Tran T; Turner A; van der Feltz-Cornelis C; van Heyningen T; van Weert H; Wagner L; Li Wang J; White J; Winkley K; Wynter K; Yamada M; Zhi Zeng Q; Zhang Y JAMA; 2020 Jun; 323(22):2290-2300. PubMed ID: 32515813 [TBL] [Abstract][Full Text] [Related]
17. A Web-based screening instrument for depression and anxiety disorders in primary care. Farvolden P; McBride C; Bagby RM; Ravitz P J Med Internet Res; 2003; 5(3):e23. PubMed ID: 14517114 [TBL] [Abstract][Full Text] [Related]
18. The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis. Marrie RA; Zhang L; Lix LM; Graff LA; Walker JR; Fisk JD; Patten SB; Hitchon CA; Bolton JM; Sareen J; El-Gabalawy R; Marriott JJ; Bernstein CN Mult Scler Relat Disord; 2018 Feb; 20():9-15. PubMed ID: 29274564 [TBL] [Abstract][Full Text] [Related]
19. Minimal Clinically Important Difference and Substantial Clinical Benefit Using PROMIS CAT in Cervical Spine Surgery. Steinhaus ME; Iyer S; Lovecchio F; Khechen B; Stein D; Ross T; Yang J; Singh K; Albert TJ; Lebl D; Huang R; Sandhu H; Rawlins B; Schwab F; Lafage V; Kim HJ Clin Spine Surg; 2019 Nov; 32(9):392-397. PubMed ID: 31569175 [TBL] [Abstract][Full Text] [Related]
20. The mental component of the short-form 12 health survey (SF-12) as a measure of depressive disorders in the general population: results with three alternative scoring methods. Vilagut G; Forero CG; Pinto-Meza A; Haro JM; de Graaf R; Bruffaerts R; Kovess V; de Girolamo G; Matschinger H; Ferrer M; Alonso J; Value Health; 2013 Jun; 16(4):564-73. PubMed ID: 23796290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]